Bendamustine Hydrochloride, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT02224729 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Stage I Multiple Myeloma
Stage II Multiple Myeloma
Stage III Multiple Myeloma

Interventions

DRUG: Bendamustine hydrochloride
DRUG: Bortezomib
DRUG: Dexamethasone

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University